BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15150117)

  • 1. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.
    Lacour S; Hammann A; Grazide S; Lagadic-Gossmann D; Athias A; Sergent O; Laurent G; Gambert P; Solary E; Dimanche-Boitrel MT
    Cancer Res; 2004 May; 64(10):3593-8. PubMed ID: 15150117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells.
    Rebillard A; Tekpli X; Meurette O; Sergent O; LeMoigne-Muller G; Vernhet L; Gorria M; Chevanne M; Christmann M; Kaina B; Counillon L; Gulbins E; Lagadic-Gossmann D; Dimanche-Boitrel MT
    Cancer Res; 2007 Aug; 67(16):7865-74. PubMed ID: 17699793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells.
    Rebillard A; Jouan-Lanhouet S; Jouan E; Legembre P; Pizon M; Sergent O; Gilot D; Tekpli X; Lagadic-Gossmann D; Dimanche-Boitrel MT
    Eur J Cancer; 2010 May; 46(8):1445-55. PubMed ID: 20202822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
    Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
    Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis.
    Gniadecki R
    Biochem Biophys Res Commun; 2004 Jul; 320(1):165-9. PubMed ID: 15207716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin augments FAS-mediated apoptosis through lipid rafts.
    Huang CR; Jin ZX; Dong L; Tong XP; Yue S; Kawanami T; Sawaki T; Sakai T; Miki M; Iwao H; Nakajima A; Masaki Y; Fukushima Y; Tanaka M; Fujita Y; Nakajima H; Okazaki T; Umehara H
    Anticancer Res; 2010 Jun; 30(6):2065-71. PubMed ID: 20651352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
    Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
    Mollinedo F; Gajate C
    Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
    Gajate C; Mollinedo F
    Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption.
    Yi JS; Choo HJ; Cho BR; Kim HM; Kim YN; Ham YM; Ko YG
    Biochem Biophys Res Commun; 2009 Jul; 385(2):154-9. PubMed ID: 19445898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].
    Xu L; Qu XJ; Liu YP; Liu J; Zhang Y; Hou KZ; Jiang YH
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):484-8. PubMed ID: 22093622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of early plasma membrane events in chemotherapy-induced cell death.
    Dimanche-Boitrel MT; Meurette O; Rebillard A; Lacour S
    Drug Resist Updat; 2005; 8(1-2):5-14. PubMed ID: 15939338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide-mediated clustering is required for CD95-DISC formation.
    Grassmé H; Cremesti A; Kolesnick R; Gulbins E
    Oncogene; 2003 Aug; 22(35):5457-70. PubMed ID: 12934106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells.
    Eramo A; Sargiacomo M; Ricci-Vitiani L; Todaro M; Stassi G; Messina CG; Parolini I; Lotti F; Sette G; Peschle C; De Maria R
    Eur J Immunol; 2004 Jul; 34(7):1930-40. PubMed ID: 15214041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of ceramide-mediated CD95 clustering.
    Grassmé H; Schwarz H; Gulbins E
    Biochem Biophys Res Commun; 2001 Jun; 284(4):1016-30. PubMed ID: 11409897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae.
    Martin S; Phillips DC; Szekely-Szucs K; Elghazi L; Desmots F; Houghton JA
    Cancer Res; 2005 Dec; 65(24):11447-58. PubMed ID: 16357153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.
    Miyaji M; Jin ZX; Yamaoka S; Amakawa R; Fukuhara S; Sato SB; Kobayashi T; Domae N; Mimori T; Bloom ET; Okazaki T; Umehara H
    J Exp Med; 2005 Jul; 202(2):249-59. PubMed ID: 16009715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
    Gajate C; Del Canto-Jañez E; Acuña AU; Amat-Guerri F; Geijo E; Santos-Beneit AM; Veldman RJ; Mollinedo F
    J Exp Med; 2004 Aug; 200(3):353-65. PubMed ID: 15289504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.
    Grassmé H; Jendrossek V; Riehle A; von Kürthy G; Berger J; Schwarz H; Weller M; Kolesnick R; Gulbins E
    Nat Med; 2003 Mar; 9(3):322-30. PubMed ID: 12563314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of cell death in head and neck cell carcinoma through alteration of cholesterol levels in lipid rafts microdomains.
    Bionda C; Athias A; Poncet D; Alphonse G; Guezguez A; Gambert P; Rodriguez-Lafrasse C; Ardail D
    Biochem Pharmacol; 2008 Feb; 75(3):761-72. PubMed ID: 17996216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.